These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35313389)

  • 1. Kinesin family member 2A links with advanced tumor stage, reduced chemosensitivity and worse prognosis in gastric cancer.
    Bai F; He Z; Zhou H; Gan W
    J Clin Lab Anal; 2022 May; 36(5):e24313. PubMed ID: 35313389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinesin family member 2A high expression correlates with advanced tumor stages and worse prognosis in non-small cell lung cancer patients.
    Wang G; Wang Z; Yu H
    J Clin Lab Anal; 2020 Apr; 34(4):e23135. PubMed ID: 31858647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of KIF2A, NDC80, CDK1, and CCNB1 in breast cancer patients: Their interaction and linkage with tumor features and prognosis.
    Wang C; Xie X; Li W; Jiang D
    J Clin Lab Anal; 2022 Sep; 36(9):e24647. PubMed ID: 35949045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
    Liang X; Xia R
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34792179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical value of kinesin superfamily protein 2A in hepatocellular carcinoma.
    Liu W; Xu C; Meng Q; Kang P
    Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101527. PubMed ID: 33713978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of kinesin family member 2A as a facilitating biomarker of disease surveillance and prognostication in cervical cancer patients.
    Lei G; Xin X; Hu X
    Ir J Med Sci; 2022 Apr; 191(2):665-670. PubMed ID: 33797694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant kinesin family member 2A signifies tumor size and invasion, and may help predict prognosis of patients with papillary thyroid carcinoma.
    Zhang X; Wu M; Peng G; Li W; Guo Z; Li H; Jiang M
    Oncol Lett; 2022 Aug; 24(2):256. PubMed ID: 35765280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinesin Family Member 2A Serves as a Potential Biomarker Reflecting More Frequent Lymph Node Metastasis and Tumor Recurrence Risk in Basal-Like Breast Cancer Patients.
    Yang H; Liu Y
    Front Surg; 2022; 9():889294. PubMed ID: 35784940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of KIF2A inhibits gastric cancer cell invasion via suppressing MT1-MMP.
    Zhao P; Lan F; Zhang H; Zeng G; Liu D
    Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1010-1018. PubMed ID: 29781531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular mechanism of kinesin family member 2A (KIF2A) underlying non-small cell lung cancer: the effect of its knockdown on malignant behaviors, stemness, chemosensitivity, and potential regulated signaling pathways.
    Chen J; Wen J; Liu D; Xu X; Fan M; Zhang Z
    Am J Transl Res; 2022; 14(1):68-85. PubMed ID: 35173830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIF2A Overexpression and Its Association with Clinicopathologic Characteristics and Poor Prognoses in Patients with Gastric Cancer.
    Zhang S; Huang F; Wang Y; Song Q; Yang X; Wu H
    Dis Markers; 2016; 2016():7484516. PubMed ID: 27773961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIF2A correlates with lymphovascular invasion and higher tumor stage, and can be used to predict worse prognosis in patients with endometrial carcinoma.
    Shi Y; Yin L; Hao Y; Wang J; Zhou W
    Oncol Lett; 2024 Aug; 28(2):396. PubMed ID: 38974111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Kinesin Family Member 2A (KIF2A) as a Promising Therapeutic Target for Osteosarcoma.
    Wang ZX; Ren SC; Chang ZS; Ren J
    Biomed Res Int; 2020; 2020():7102757. PubMed ID: 33204709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIF2A promotes the progression via AKT signaling pathway and is upregulated by transcription factor ETV4 in human gastric cancer.
    Zhang X; Wang Y; Liu X; Zhao A; Yang Z; Kong F; Sun L; Yu Y; Jiang L
    Biomed Pharmacother; 2020 May; 125():109840. PubMed ID: 32106376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinesin family member 2A promotes cancer cell viability, mobility, stemness, and chemoresistance to cisplatin by activating the PI3K/AKT/VEGF signaling pathway in non-small cell lung cancer.
    Xu L; Zhang X; Wang Z; Zhao X; Zhao L; Hu Y
    Am J Transl Res; 2021; 13(4):2060-2076. PubMed ID: 34017375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIF2A overexpression and its association with clinicopathologic characteristics and unfavorable prognosis in colorectal cancer.
    Fan X; Wang X; Zhu H; Wang W; Zhang S; Wang Z
    Tumour Biol; 2015 Nov; 36(11):8895-902. PubMed ID: 26070867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High KIF2A expression promotes proliferation, migration and predicts poor prognosis in lung adenocarcinoma.
    Xie T; Li X; Ye F; Lu C; Huang H; Wang F; Cao X; Zhong C
    Biochem Biophys Res Commun; 2018 Feb; 497(1):65-72. PubMed ID: 29427669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of KIF2A on the prognosis of nasopharyngeal carcinoma and nasopharyngeal carcinoma cells.
    Zhang Q; Lu D; Liu W; Ye S; Guo H; Liao T; Chen C
    Oncol Lett; 2019 Sep; 18(3):2718-2723. PubMed ID: 31452750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer.
    Wang J; Ma S; Ma R; Qu X; Liu W; Lv C; Zhao S; Gong Y
    BMC Cancer; 2014 Jun; 14():461. PubMed ID: 24950762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer.
    Wang D; Zhu H; Ye Q; Wang C; Xu Y
    Medicine (Baltimore); 2016 Feb; 95(8):e2803. PubMed ID: 26937910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.